Success rate for new ARVs entering phases II–III surpassed 32% from 2003–2011 U.S. ADAP Prescribing Practices Closely Match Recent ARV Guidelines by Polly Clayden and Mark Harrington As we were putting together the 2011 Pipeline Report this summer, we decided…
By Coco Jervis and Sue Perez Negligible Increases for AIDS, TB, Viral Hepatitis Treatment and Research On Monday, February 1, 2010, President Barack Obama unveiled his fiscal year (FY) 2011 budget to the U.S. Congress. Global health programs were allocated…
by Coco Jervis Cuba boasts model health outcomes but at what costs to human rights? In November 2009 TAG’s senior policy associate, Coco Jervis, attended the Global Forum for Health Research meeting in Havana, Cuba, under a special license that…
By Javid Syed BOTUSA study strongly supports continuous preventive IPT for people with HIV Tuberculosis (TB) remains the leading cause of death among people living with HIV. The World Health Organization’s 2009 report Global Tuberculosis Control: Epidemiology, Strategy, Financing reported…
By Claire Wingfield After 40 years of scientific stagnation, it is beginning to be an exciting time in tuberculosis treatment research. Tuberculosis (TB) is the leading killer of people with HIV worldwide, accounting for more than quarter of all HIV…
By Richard Jefferys On Friday, January 15, the National Institutes of Allergy & Infectious Diseases (NIAID) sponsored a scientific workshop entitled “The Next Challenge: Elimination of HIV Reservoirs.” The event took place during the Keystone conference on HIV pathogenesis in…
By Mark Harrington Safer and more effective drug combinations included in new guidelines... Unusually, there was something to celebrate on World AIDS Day in 2009, even if it was only on paper. The World Health Organization (WHO) updated its antiretroviral…
By Coco Jervis Big changes are planned for the $300 million AIDS clinical trials networks funded by the U.S. National Institutes of Health (NIH). Founded in 1987 at the height of the AIDS crisis, the networks are credited with numerous…
An Interview with Polly Harrison, founder of the Alliance for Microbicide Development Polly Harrison founded and led the Alliance for Microbicide Development (http://www.microbicide.org) from 1998 to early 2010. She is now a senior policy advisor at AVAC. TAG worked closely…
By Richard Jefferys One of the main sources of pessimism about prospects for an effective HIV vaccine has been the generally poor results obtained in animal models. In particular, a stringent system involving rhesus macaque monkeys challenged with highly pathogenic…